UK markets open in 2 hours 1 minute
  • NIKKEI 225

    27,113.13
    -475.24 (-1.72%)
     
  • HANG SENG

    24,656.46
    0.00 (0.00%)
     
  • CRUDE OIL

    83.64
    +0.33 (+0.40%)
     
  • GOLD FUTURES

    1,842.50
    +0.80 (+0.04%)
     
  • DOW

    34,364.50
    +99.13 (+0.29%)
     
  • BTC-GBP

    26,805.58
    -7.15 (-0.03%)
     
  • CMC Crypto 200

    821.53
    +10.93 (+1.35%)
     
  • ^IXIC

    13,855.13
    +86.21 (+0.63%)
     
  • ^FTAS

    4,099.16
    -118.15 (-2.80%)
     

Global Pharmaceutical Industry 2021 Highlights and What to Expect in 2022

·2-min read

Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Industry Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical industry is witnessing dynamic trends following the coronavirus pandemic and is adapting to new challenges and opportunities. This study analyzes the 2021 highlights in the global pharmaceutical industry and provides forecasts for the next year and beyond.

It addresses the impact of innovative modalities, technologies, and recent drug approvals, such as gene and cell therapy, monoclonal antibodies,

RNA-based therapeutics, and the increasing use of health data through real-world evidence and artificial intelligence. The need to gain access to early-stage drugs and novel technologies has led to a higher rate of licensing and mergers with small biopharma that are developing the same. In addition, patient engagement has been driving digital partnerships centred around digital therapeutics, decentralized clinical trials, remote monitoring, and telemedicine.

The study also provides critical insights into the key regulatory, reimbursement, and policy updates for 2021, ranging from health data standardization and quality regulation to direct drug pricing negotiations and biosimilars & generics encouragement.


Key Topics Covered:

1. Strategic Imperatives

2. Growth Opportunity Universe

  • Pharmaceuticals - Factors Affecting Growth

  • Growth Opportunity Analysis for the Global Pharmaceutical Industry

  • 2021 Highlights and What to Expect in 2022

  • Growth Drivers

  • Growth Restraints

  • Market Snapshot - Next-generation Biologics Modalities

  • Key FDA Approvals for Novel Drugs

  • Key M&A Deals

  • Key M&A Deals in the Pharma Industry

  • Key Product Licensing Deals

  • Key Digital Partnership Deals

  • Key Regulatory, Reimbursement, and Policy Updates

3. Growth Opportunity Universe

  • Growth Opportunity 1: Novel Drug Modalities and RNA Therapeutics Transforming R&D Productivity

  • Growth Opportunity 2: Integrated and RWE-supported Drug Development Platforms/Solutions to Improve User Experience

For more information about this report visit https://www.researchandmarkets.com/r/ucbw8l

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting